Aumed, a.s., Komořanská 326/63, 143 14 Praha - Modřany, Česká republika

+420 603 587 701 English

New sampling set GARGTEST

gargtest_fotosady_3

AUMED, a.s. collaborated on the development of a new self-sampling set based on the principle of gargling of the oral cavity and pharynx. The new sampling set was named GARGTEST and was developed in cooperation with the Institute of Molecular and Translational. The samples are evaluated in the laboratory by common methods based on nucleic acid amplification (PCR, LAMP, etc.). for the presence of viruses infecting the oral cavity and upper respiratory tract using commonly available nucleic acid isolation and detection methods based on nucleic acid amplification.

The new collection is therefore much more pleasant and completely painless. Instead of pushing the sticks into the nose, it is enough to gargle a sip of ordinary water for 20-30 seconds and then empty this content from the mouth into the enclosed collection container containing the transport powder. The user then closes the container and packs it according to the instructions. He will perform this procedure either at the sampling point or at home, from where he will then deliver the sample to the sampling point, to the laboratory or, for example, to his doctor.

The combination of the new sampling kit and the AUMED test RT-LAMP Assay SARS-CoV-2 test kit creates completely new possibilities for the detection of new coronavirus in the population. Painless and fast collection without queues will be followed by fast and reliable diagnostics!

AUMED a.s. ensures the production of the sampling set. If you are interested, contact us by email info@aumed.cz and we will contact you immediately with a price offer depending on the number of required sets.

 

MORE ARTICLES

Aumed Pharma a.s. launches new food supplement Gut Guard

07. 03. 2024

Our subsidiary Aumed Pharma a.s. launches food supplement Gut Guard. Gut Guard probiotics contain a combination of 13 vital probiotic…

AUMED, a.s. received support for the development of a preparation with phages for recurrent bacterial vaginosis

06. 03. 2024

AUMED received support for the project “Development of an antibacterial preparation with phages for recurrent bacterial vaginosis”, registration number CZ.01.01.01/01/22_002/0000523….

AUMED, a.s. received support for the development of a vaccine against Staphylococcus aureus

18. 12. 2023

AUMED received support for the project “Development of a new vaccine against Staphylococcus aureus”, registration number CZ.01.01.01/01/22_002/0000585. Staphylococcus aureus causes…

Research projects of Aumed, a.s. are financed by the European Structural Funds and with financial support from the state budget through the Ministry of Industry and Trade. A complete list of all ongoing and completed projects with this support can be found here.

European Union
European Regional Development Fund
OP Enterprise and Innovation for Competitiveness


Tel.: +420 603 587 701
Komořanská 326/63, 143 14 Praha - Modřany, Česká republika
(c) 2017, Aumed a.s